You just read:

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

News provided by

DelMar Pharmaceuticals, Inc.

Sep 18, 2017, 08:00 ET